Elafibranor: A potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
Semaglutide (found in Ozempic and Wegovy) mimics a natural hormone (glucagon-like peptide-1, or GLP-1) to control appetite and help you feel satisfied with less food
Safety Advantage: Semaglutide The risk of serious side effects from GLP-1 receptor agonists is relatively low, but common side effects like nausea, indigestion, and other forms of GI upset can be expected by most users.6 These digestive issues tend to fade as your body adjusts to the medication and you make lifestyle adjustments based on how the medication affects your metabolism
When Semaglutide is administered at a higher dose, it suppresses appetite in the brain
The test ($99 add-on after your first month) examines genetic variants in GLP-1 receptor and peptide-metabolism pathways, revealing how strongly your body responds to semaglutide's gastric effects
It has documented independent effects on lipid panels that show up in lab work, often within the first few months of treatment